Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.
Status:
Terminated
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to assess the safety and effectiveness of fondaparinux, a new
drug to prevent blood clotting in the continuous dialysis machine used in intensive care
patients who have kidney failure.